USP8 inhibition suppresses prostate tumorigenesis via promoting RICTOR degradation to inhibit mTORC2 signaling

RICTOR plays an essential role in regulating mechanistic target of rapamycin complex 2 (mTORC2) kinase activity, but it remains largely elusive how RICTOR is aberrantly activated in human prostate cancer (PrCa). Here, we identify RICTOR as a substrate of Cullin 3–based ubiquitin ligase adaptor SPOP, an important tumor suppressor in PrCa. SPOP deficiency or cancer-derived SPOP mutations disrupt SPOP-mediated degradation of RICTOR, thereby promoting PrCa progression. Furthermore, we identify USP8 as its upstream deubiquitinase, and inhibition of USP8 specifically suppresses RICTOR/mTORC2 activity without affecting mTORC1. As such, the USP8 inhibitor induces RICTOR degradation concomitant with marked tumor suppression in vivo. Hence, these findings reveal an SPOP-USP8-RICTOR regulatory circuit that underlies PrCa tumorigenesis and provides a rationale for targeting RICTOR via USP8 inhibition as a therapeutic strategy for patients with PrCa.

Authors

Institutions

Publication Details

Journal
Science Advances
Published
2026-11-18
DOI
https://doi.org/10.1126/sciadv.aeh0679
Primary Topic
Ubiquitin and proteasome pathways
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

USP8 inhibition suppresses prostate tumorigenesis via promoting RICTOR degradation to inhibit mTORC2 signaling

Wenyi Wei, Weiwei Jiang, Fabin Dang, Hiroyuki Inuzuka et al.
Science Advances
Ubiquitin and proteasome pathways
article

USP8 inhibition suppresses prostate tumorigenesis via promoting RICTOR degradation to inhibit mTORC2 signaling

Wenyi Wei, Weiwei Jiang, Fabin Dang, Hiroyuki Inuzuka, Peiqiang Yan, Jingchao Wang, Li Chen, Lei Li, Bo Liu, Daoyuan Huang, Tao Hou, Yihang Qi
article en

Abstract

RICTOR plays an essential role in regulating mechanistic target of rapamycin complex 2 (mTORC2) kinase activity, but it remains largely elusive how RICTOR is aberrantly activated in human prostate cancer (PrCa). Here, we identify RICTOR as a substrate of Cullin 3–based ubiquitin ligase adaptor SPOP, an important tumor suppressor in PrCa. SPOP deficiency or cancer-derived SPOP mutations disrupt SPOP-mediated degradation of RICTOR, thereby promoting PrCa progression. Furthermore, we identify USP8 as its upstream deubiquitinase, and inhibition of USP8 specifically suppresses RICTOR/mTORC2 activity without affecting mTORC1. As such, the USP8 inhibitor induces RICTOR degradation concomitant with marked tumor suppression in vivo. Hence, these findings reveal an SPOP-USP8-RICTOR regulatory circuit that underlies PrCa tumorigenesis and provides a rationale for targeting RICTOR via USP8 inhibition as a therapeutic strategy for patients with PrCa.

Science AdvancesVol. 12(47)
Beth Israel Deaconess Medical Center (US), Harvard University (US), First Affiliated Hospital of Xi'an Jiaotong University (CN), Case Comprehensive Cancer Center (US), Case Western Reserve University (US)
Beth Israel Deaconess Medical Center
Good health and well-being
Ubiquitin and proteasome pathways
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon